Your browser doesn't support javascript.
loading
Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer.
Kitamura, T; Suzuki, M; Nishimatsu, H; Kurosaki, T; Enomoto, Y; Fukuhara, H; Kume, H; Takeuchi, T; Miao, L; Jiangang, H; Xiaoqiang, L.
Affiliation
  • Kitamura T; Department of Urology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. tadkitamura-tky@umin.ac.jp
Aktuelle Urol ; 41 Suppl 1: S34-40, 2010 Jan.
Article in En | MEDLINE | ID: mdl-20094950
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Gonadotropin-Releasing Hormone / Leuprolide / Goserelin / Antineoplastic Agents, Alkylating / Estramustine Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Aktuelle Urol Year: 2010 Document type: Article Affiliation country: Japan Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma / Gonadotropin-Releasing Hormone / Leuprolide / Goserelin / Antineoplastic Agents, Alkylating / Estramustine Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Aktuelle Urol Year: 2010 Document type: Article Affiliation country: Japan Country of publication: Germany